MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202439037406 A) filed by Debasish Banerjee, Kolkata, West Bengal, on May 13, 2024, for 'an improved method for evaluation of bioavailability and bioequivalence in vivo in humans.'
Inventor(s) include Debasish Banerjee; Subhakanta Dhal; Soumyaranjan Pahadsingh; Sunita Behera; and Ananya Tripathy.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "Here' cornpared the main application, we have developed a method conrparison a more accurate method for of drug effects, where the effect of drugs, have been monitored throughout the entire duratron of action' after administration to human subjects, giving thereby a better evaluation of drug action' TJe have by this method compared the pharmacological effects of gliclazide and,glyburide. we have also' bv this rnethod, compared the effect of acarbose, to sucrose, the substrate for amyrase and have found that acarbose has an affinity 57000 times that of sucrose, thereby explaining why acarbose replaces sucrose so easily on the amylase receptor, an achievement done for the 1st time in the world."
Disclaimer: Curated by HT Syndication.
